$ATER

Aterian (ATER) secured up to $1 million in 8% note financing from stockholder Chen Zhipeng. The unsecured note matures in 8 months, with repayment options including cash, private placement, or conversion to common stock. The agreement was signed on October 20, 2026, according to the company's SEC filing.

Aterian, Inc. (ATER) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 20, 2026, Aterian, Inc., a Delaware corporation (the “Company”), entered into an unsecured promissory note (the “Note”) with Chen Zhipeng (the “Lender”), a stockholder of the Company, pursuant to which the Lender ag

Aterian Inc. (ATER) engaged former CEO Arturo Rodriguez as an independent contractor on October 2, 2026, following his employment termination on September 30, 2026. Rodriguez will provide limited advisory services under a consulting agreement, as approved by the board.

Aterian, Inc. (ATER) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 4.01. Changes in Registrant’s Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm On October 2, 2026, the Audit Committee of the Board of Directors (the “Committee”) of Aterian, Inc. (the “Company”) approved the dismissal of UHY LLP (“UHY”)

Michelle Chiam Sin Ling disclosed a 10% stake in Aterian, Inc. (ATER) via a 13D filing, acquiring 26.1M common shares from David E. Lazar. The deal included appointing William H. Crampton to Aterian's board, suggesting governance changes. Chiam may pursue additional investments but has no immediate plans for major corporate actions.

Aterian, Inc. (ATER) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 September 28, 2026 Subject: CVR Cash Payment Notice for Distribution to Holders of Contingent Value Rights (CUSIP: 021CVR014) Delivered to: Broadridge Corporate Issuer Solutions, LLC, solely in its capacity as Rights Agent, for distribution to the Holders Dear CVR Ho

Aterian, Inc. (ATER) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 3.01 Notice of Failure to Satisfy a Continued Listing Rule or Standard Bid Price Notice On September 2, 2026, Aterian, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (the “Staff”) indicating that, based upon the cl

Aterian, Inc. (ATER) is scheduled to report Q2 2026 results on Aug. 10 at 8:00 AM ET. The consensus estimates cited for Q2 2026 call for revenue of $20.30 million and EPS of -$0.17. The figures are presented on the company’s financials page.

Aterian, Inc. (ATER) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 3 ex_989840.htm EXHIBIT 10.1 ex_989840.htm Exhibit 10.1 CONTINGENT VALUE RIGHTS AGREEMENT by and between ATERIAN, INC., a Delaware corporation, and BROADRIDGE CORPORATE ISSUER SOLUTIONS, LLC , a Pennsylvania limited liability company, Dated as of July 17, 2026 i Table of

Aterian, Inc. (NASDAQ: ATER) adjourned its special stockholder meeting from July 10 to July 17, 2026. The vote concerns an asset sale of substantially all brand portfolios to Trademark Global, LLC and a related investment transaction. Aterian says the $18 million sale could return $0.85 to $1.14 per share, plus a $7 million investment.